OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

ADDEX N/  CH0029850754  /

SIX Swiss Exchange
2024-08-28  5:30:01 PM Chg. -0.0066 Volume Bid5:48:32 PM Ask5:48:32 PM Market Capitalization Dividend Y. P/E Ratio
0.0700CHF -8.62% 3.58 mill.
Turnover: 282,652.4682		 0.0696Bid Size: 20,000 0.0808Ask Size: 20,000 12.48 mill.CHF - -
GlobeNewswire 07-22 Addex’s Partner Discontinues ADX71149 development in Epilepsy
GlobeNewswire 07-15 Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International ...
GlobeNewswire 07-12 Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
GlobeNewswire 07-01 Addex Shareholders Approve All Resolutions at Annual General Meeting
GlobeNewswire 06-06 Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire 06-05 Addex Convenes Annual General Meeting 2024
GlobeNewswire 05-31 Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire 05-08 Addex to Present at Bio€quity Europe 2024
GlobeNewswire 04-29 Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GlobeNewswire 04-19 Addex to Present at the Swiss Biotech Day 2024
GlobeNewswire 04-18 Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 04-11 Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire 04-03 Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire 03-14 Addex to Present at the Bio-Europe Spring 2024 Conference
GlobeNewswire 01-31 Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire 01-09 Addex to Present at the Swiss Equities Baader Conference
GlobeNewswire 01-05 Addex to Present at Biotech Showcase™ 2024
GlobeNewswire 2023-12-14 Addex Creates Treasury Shares
GlobeNewswire 2023-11-29 Addex Reports Q3 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-28 Addex Convenes Extraordinary General Meeting
GlobeNewswire 2023-11-23 Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire 2023-11-14 Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
GlobeNewswire 2023-11-08 Addex Regains Nasdaq Listing Compliance
GlobeNewswire 2023-11-07 US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire 2023-11-02 Addex Announces Participation in the Bio-Europe 2023 Conference